Microdialysis and Pharmacokinetic Study of TR-701
Clinical trial NCT00666601 · COMPLETED
Trial details
- NCT number
- NCT00666601
- Sponsor
- Trius Therapeutics LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-04-04
- Primary completion
- 2008-08-12
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.